Risk stratification and outcomes in hemodynamically stable patients with acute pulmonary embolism: a prospective, multicentre, cohort study with three months of follow-up

被引:67
作者
Bova, C. [1 ]
Pesavento, R. [2 ]
Marchiori, A. [3 ]
Palla, A. [4 ]
Enea, I. [5 ]
Pengo, V. [2 ]
Visona, A. [6 ]
Noto, A. [1 ]
Prandoni, P. [2 ]
机构
[1] Azienda Osped, Dept Internal Med, Cosenza, Italy
[2] Univ Padua, Dept Cardiothorac & Vasc Sci, Padua, Italy
[3] S Anthony Hosp, Dept Emergency Med, Padua, Italy
[4] Univ Pisa, Cardiothorac Dept, Pisa, Italy
[5] Osped S Sebastiano, Emergency Dept, Caserta, Italy
[6] Osped S Giacomo, Angiol Dept, Castelfranco Veneto, Italy
关键词
hemodynamic stable; prognosis; pulmonary embolism; RIGHT-VENTRICULAR DYSFUNCTION; PROGNOSTIC VALUE; ECHOCARDIOGRAPHY; MANAGEMENT; ALTEPLASE; PRESSURE; HEPARIN;
D O I
10.1111/j.1538-7836.2009.03345.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The role of risk stratification in normotensive patients with acute pulmonary embolism (PE) is still unclear. Objectives: We evaluated, in these patients, the usefulness of six prognostic markers for predicting in-hospital adverse events related to PE and 3-month mortality. Patients/Methods: Two hundred and one consecutive patients with confirmed acute PE and normal blood pressure, who were administered conventional anticoagulation, were recruited in a multicentre prospective cohort study with 3 months of follow-up. At baseline, they received a comprehensive risk-evaluation including echocardiographic assessment of right ventricular dysfunction, determination of troponin I, brain natriuretic peptide and D-dimer, arterial blood gas analysis and a clinical score. Primary outcome of the study was PE-related in-hospital death or clinical deterioration. Secondary outcomes were in-hospital and 3-month all-cause mortality. Results: The primary outcome occurred in one patient (0.5%), who died from PE during hospitalization. The in-hospital and 3-month all-cause mortality were 2% and 9%, respectively. None of the prognostic markers was predictive of the primary outcome. Clinical score, troponin I and hypoxemia predicted in-hospital all-cause mortality (P = 0.02, 0.01 and < 0.01, respectively). Clinical score (HR, 4.7; 95% CI, 1.9-12.0), D-dimer (4.8; 1.4-16.3), hypoxemia (5.7; 2.1-15.1) and troponin I (7.5; 2.5-22.7) were predictors of 3-month all-cause mortality on univariate analysis. On multivariate analysis clinical score and troponin I remained independently predictive. Conclusions: We did not find prognostic markers useful as predictors of in-hospital PE-related adverse events. Clinical score, troponin I and hypoxemia predicted in-hospital all-cause mortality. Clinical score and troponin I independently predicted 3-month all-cause mortality.
引用
收藏
页码:938 / 944
页数:7
相关论文
共 27 条
  • [1] Derivation and validation of a prognostic model for pulmonary embolism
    Aujesky, D
    Obrosky, DS
    Stone, RA
    Auble, TE
    Perrier, A
    Cornuz, J
    Roy, PM
    Fine, MJ
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (08) : 1041 - 1046
  • [2] Prognostic value of D-dimer in patients with pulmonary embolism
    Aujesky, Drahomir
    Roy, Pierre-Marie
    Guy, Meyer
    Cornuz, Jacques
    Sanchez, Olivier
    Perrier, Arnaud
    [J]. THROMBOSIS AND HAEMOSTASIS, 2006, 96 (04) : 478 - 482
  • [3] Prognostic value of troponins in acute pulmonary embolism - A meta-analysis
    Becattini, Cecilia
    Vedovati, Maria Cristina
    Agnelli, Giancarlo
    [J]. CIRCULATION, 2007, 116 (04) : 427 - 433
  • [4] Antithrombotic therapy for venous thromboembolic disease
    Büller, HR
    Agnelli, G
    Hull, RD
    Hyers, TA
    Prins, AH
    Raskob, GE
    [J]. CHEST, 2004, 126 (03) : 401S - 428S
  • [5] THE CLINICAL COURSE OF PULMONARY-EMBOLISM
    CARSON, JL
    KELLEY, MA
    DUFF, A
    WEG, JG
    FULKERSON, WJ
    PALEVSKY, HI
    SCHWARTZ, JS
    THOMPSON, BT
    POPOVICH, J
    HOBBINS, TE
    SPERA, MA
    ALAVI, A
    TERRIN, ML
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (19) : 1240 - 1245
  • [6] Risk of fatal pulmonary embolism in patients with treated venous thromboembolism
    Douketis, JD
    Kearon, C
    Bates, S
    Duku, EK
    Ginsberg, JS
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (06): : 458 - 462
  • [7] Echocardiography in the management of pulmonary embolism
    Goldhaber, SZ
    [J]. ANNALS OF INTERNAL MEDICINE, 2002, 136 (09) : 691 - 700
  • [8] Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER)
    Goldhaber, SZ
    Visani, L
    De Rosa, M
    [J]. LANCET, 1999, 353 (9162) : 1386 - 1389
  • [9] ALTEPLASE VERSUS HEPARIN IN ACUTE PULMONARY-EMBOLISM - RANDOMIZED TRIAL ASSESSING RIGHT-VENTRICULAR FUNCTION AND PULMONARY PERFUSION
    GOLDHABER, SZ
    HAIRE, WD
    FELDSTEIN, ML
    MILLER, M
    TOLTZIS, R
    SMITH, JL
    DASILVA, AMT
    COME, PC
    LEE, RT
    PARKER, JA
    MOGTADER, A
    MCDONOUGH, TJ
    BRAUNWALD, E
    [J]. LANCET, 1993, 341 (8844) : 507 - 511
  • [10] Goldhaber SZ, 2001, THROMB HAEMOSTASIS, V86, P444